Study of pancreas (and sometimes kidney) transplant outcomes
Part of Hormones & metabolism clinical trials.
This study looks at people who receive a pancreas transplant, with or without a same-time kidney transplant, and follows them to understand their results. It may help improve how transplant teams choose patients and manage care after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- Be scheduled to receive a first or second pancreas transplant, with or without a simultaneous kidney transplant.
- If you can become pregnant, have a negative pregnancy blood test before starting.
- Your surgical team (kidney doctor, transplant surgeon, and anesthesia doctor) must confirm you are fit for surgery.
- Sign and date an informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood sugar problems in people who have had a stem cell transplant from a donor. It may help doctors learn how to better manage or prevent diabetes after a transplant.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
This study is a registry that collects information about people who have had a pancreas transplant. The goal is to learn how to improve the way donor pancreases are preserved, which might help more transplants succeed in the future.
This study checks how well transplanted islet cells are working over time and monitors long-term safety. If you previously received an islet transplant and are still using medicine to prevent rejection, you may be followed again.
This study uses MRI scans to see how well your new pancreas and kidney are working after transplant. It may help doctors monitor your transplant without needing risky procedures.
This study compares two ways of treating acute rejection (when the immune system attacks the new organ) in people who have had a kidney or combined kidney-pancreas transplant. It looks at whether adding a different approach helps protect the transplant long-term.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.